Management of perioperative ventricular dysfunction

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 1, 2001, Pages 90-106

  Griffin, Michael J ^a   Hines, Roberta L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart assist devices; Inotropes; Ventricular dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; AMRINONE; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOLDOPAM; GLYCERYL TRINITRATE; HEPARIN; INOTROPIC AGENT; ISOPRENALINE; MILRINONE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; THYROID HORMONE;

ACUTE HEART INFARCTION; AORTA BALLOON; CARDIOMYOPLASTY; CARDIOPULMONARY BYPASS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; HEART AFTERLOAD; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART PRELOAD; HEART RATE; HEART RHYTHM; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTILITY; HUMAN; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0035114442     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.20283     Document Type: Article

References (162)

1. Cardiac failure in coronary heart disease
2. The role of cytokines in the failing human heart
3. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
4. Pathogenesis and management of acute heart failure and cardiogenic shock: Role of inotropic therapy
5. Prognosis of congestive heart failure and predictors of mortality
6. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure
7. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension
8. Efficacy of nitroprusside treatment in the postcardiotomy low-output syndrome needing intra-aortic balloon pump
9. A cooperative multicenter study of captopril in congestive heart failure: Hemodynamic effects and long-term response
10. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction
11. Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: A prospective randomized study
12. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery
13. Perioperative renal preservation: Dopexamine and fenoldopam - New agents to augment renal performance
14. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
15. Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine-1 receptor agonism with nitroprusside
16. Selective dopamine-1 receptor agonist augments regional myocardial blood flow
17. Fenoldopam: A new parenteral antihypertensive: Consensus roundtable on the management of perioperative hypertension and hypertensive crises
18. DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension
19. Fenoldopam: A new dopamine agonist for the treatment of hypertensive urgencies and emergencies
20. Prostaglandin E1 for refractory right heart failure after coronary artery bypass grafting
21. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep
22. Vasodilator properties of prostacyclin after coronary artery bypass surgery
23. A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery
24. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs
25. Adrenergic receptors in man: Direct identification, physiologic regulation, and clinical alterations
26. From epinephrine to cyclic AMP
27. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts
28. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure
29. Beta-adrenergic receptors and receptor signaling in heart failure
30. Beta-adrenergic receptor function is acutely altered in surgical patients
31. Beta-adrenergic receptor changes during coronary artery bypass grafting
32. Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Duke Heart Center Perioperative Desensitization Group
33. Acute depression of myocardial beta-adrenergic receptor signaling during cardiopulmonary bypass: Impairment of the adenylyl cyclase moiety. Duke Heart Center Perioperative Desensitization Group
34. Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass: Evidence for early uncoupling and late downregulation
35. Epinephrine and left ventricular function in humans: Effects of beta-1 vs nonselective beta blockade
36. Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery
37. Effects of 1-epinephrine on hemodynamic and cardiac function in coronary disease: Dose response studies
38. Factors that predict the use of positive inotropic drug support after cardiac valve surgery
39. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man
40. Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man
41. Comparison of dopamine and dobutamine in patients requiring postoperative circulatory support
42. Comparison of dopamine and dobutamine therapy during intraaortic balloon pumping for the treatment of postcardiotomy low-output syndrome
43. Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients
44. Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: A study in normal healthy volunteers
45. Dopexamine: A novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors
46. The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery
47. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery
48. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting
49. Haemodynamic effects of different doses of dopexamine hydrochloride in low cardiac output states following cardiac surgery
50. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine
51. Protective effects of dopexamine hydrochloride in renal failure after acute haemorrhage in anaesthetized dogs
52. Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting
53. Gastrointestinal permeability following cardiopulmonary bypass: A randomised study comparing the effects of dopamine and dopexamine
54. Treatment of milrinone-associated tachycardia with beta-blockers
55. Hemodynamic and biological effects of IV milrinone in patients with a low cardiac output syndrome following cardiac surgery
56. Short-term use of intravenous milrinone for heart failure
57. The European Milrinone Multicentre Trial Group: Intravenous milrinone following cardiac surgery: Effects of bolus infusion followed by variable dose maintenance fusion
58. The European Milrinone Multicentre Trial Group: Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response
59. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass
60. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery
61. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery
62. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients
63. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery
64. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: A comparison of their effects on hemodynamics and outcome
65. The role of amrinone in treating heart failure during and after coronary artery surgery supported by cardiopulmonary bypass
66. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction
67. The in vivo effect of phosphodiesterase inhibitors on the human internal mamary artery
68. The effects of thyroid hormones on the heart following global ischemia: A clinical and experimental study
69. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3′, 5′-adenosine monophosphate
70. 3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: An initial experience in patients undergoing open heart surgery
71. Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery
72. Thyroid hormone treatment after coronary artery bypass surgery
73. Triiodothyronine therapy in open-heart surgery: From hope to disappointment
74. Effect of chronic and acute thyroid hormone reduction on perioperative outcome
75. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia
76. Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: Results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery
77. Additive effects of dobutamine and amfinone on myocardial contractility and ventricular performance in patients with severe heart failure
78. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart
79. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans
80. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass
81. The effect of milrinone on hemodynamics and left ventricular function after emerging from cardiopulmonary bypass
82. A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients
83. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients
84. The combined use of noradrenaline, amrinone and nitroglycerin in the management of severe low cardiac output after coronary artery surgery
85. Treatment of low cardiac output after aortocoronary artery bypass surgery using a combination of norepinephrine and amrinone
86. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
87. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement
88. + channel mediates hypotension in endotoxemia and hypoxic lactic acidoses in dogs
89. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock
90. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations
91. Influence of glucoseinsulin-potassium on left ventricular function during coronary artery bypass grafting
92. Growth hormone therapy for heart failure: Swimming against the stream
93. Calcium entry attenuates adenylyl cyclase activity: A possible mechanism for calcium-induced catecholamine resistance
94. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone
95. Effects of calcium on left ventricular function early after cardiopulmonary bypass
96. A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for inotropic support after emergence from cardiopulmonary bypass
97. Is calcium or ephedrine superior to placebo for emergence from cardiopulmonary bypass?
98. The effect of calcium on pulmonary vascular resistance and right ventricular function
99. Magnesium deficiency and cardiogenic shock after cardiopulmonary bypass
100. Predictors of low cardiac output syndrome after coronary artery bypass
101. Successful treatment of low cardiac output syndrome with beta-adrenergic blockade because of improved effectiveness of an intra-aortic balloon pump
102. Use of esmolol in hypertension after cardiac surgery
103. Perioperative use of esmolol
104. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease
105. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
106. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less
107. Use of percutaneously inserted cardiopulmonary bypass in the cardiac catheterization laboratory
108. Emergent percutaneous cardiopulmonary bypass in patients having cardiovascular collapse in the cardiac catheterization laboratory
109. Heparin coated pereutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery
110. Mechanical cardiac assistance
111. Circulatory assist devices in congestive heart failure
112. Therapeutic and physiological artificial heart: Future prospects
113. Transesophageal echocardiography in patients with mechanical circulatory assistance
114. Experience with right ventricular assist devices for perioperative right-sided circulatory failure
115. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices
116. Mechanical ventricular support using pulsatile Abiomed BVS 5000 and centrifugal Biomedicus pump in postcardiotomy shock
117. Cardiac assist devices
118. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system
119. Improved left ventricular function after chronic left ventricular unloading
120. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
121. Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy
122. Assessment of submaximal exercise capacity in patients with left ventricular assist devices
123. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading
124. The REMATCH trial: Rationale, design, and endpoints. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
125. Improved survival after Hemopump insertion in patients experiencing postcardiotomy cardiogenic shock during cardiopulmonary bypass
126. Circulatory support of cardiac interventional procedures with the Hemopump cardiac assist system
127. Postoperative management of patients with Hemopump support after coronary artery bypass grafting
128. Intraoperative implantation of percutaneous left ventricular assist system
129. Adult placenta: The ECMO experience in patients with a coronary artery bypass graft and postcardiotomy cardiogenic shock
130. Latissimus dorsi dynamic cardiomyoplasty
131. Dynamic cardiomyoplasty: At the crossroads
132. Permanent cardiac assistance from skeletal muscle: A prospect for the new millennium
133. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
134. Surgical therapy for dilated cardiomyopathy
135. Open chest and delayed sternal closure after cardiac surgery
136. Reperfusion therapy in cardiogenic shock complicating acute myocardial infarction
137. Cardiogenic shock
138. Intraaortic balloon pump support during high-risk coronary angioplasty
139. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock
140. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock
141. Surgical treatment of acute myocardial infarct: Clinical considerations
142. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100, 000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group
143. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow
144. Secondary prevention of myocardial infarction: Role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors
145. Anti-ischemic properties of ACE-inhibitors
146. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: Possible mechanisms
147. Effects of diastolic transeptal pressure gradient on ventricular septal position and motion
148. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction
149. Adenosine is a selective pulmonary vasodilator in cardiac surgical patients
150. Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: End-systolic pressure - Volume relation
151. Response to inhaled nitric oxide in patients with acute right heart syndrome
152. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation
153. Nitric oxide inhalation in acute pulmonary hypertension after cardiac surgery reduces oxygen concentration and improves mechanical ventilation but not mortality
154. Selective pulmonary vasodilation in cardiac surgical patients
155. Variable response to inhaled nitric oxide after cardiac surgery
156. Effective control of refractory pulmonary hypertension after cardiac operations
157. Usefulness of nitric oxide inhalation for management of right ventricular failure after heart transplantation in patients with pretransplant pulmonary hypertension
158. Pulmonary artery balloon counterpulsation for acute right ventricular failure
159. Temporary extracorporeal support of the right ventricle
160. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system: A comparative study
161. Efficacy and safety of a percutaneous right ventricular assist system
162. Right ventricular function in an operating room model of mechanical left ventricular assistance and its effects in patients with depressed left ventricular function